Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

Depression Clinical Trial

— MoodTECH  

Official title:

Technology Assisted Intervention for the Treatment and Prevention of Depression

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01912664
• Other study ID #: P20MH090318-STU00052134
• Status: Completed
• Phase: N/A
• First received: July 29, 2013
• Last updated: September 23, 2016
• Start date: October 2015
• Est. completion date: September 2016

Study information

• Verified date: September 2016
• Source: Northwestern University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal GovernmentUnited States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The mission of this project is to develop novel systems of care that can provide efficacious, scalable, cost-effective, participant friendly technology assisted behavioral interventions (TABIs) for the treatment of depression in adults. The investigators define TABIs as interventions that use information and telecommunications technologies such as the internet, mobile or traditional phones, computers and/or other technologies to support and deliver psychological and behavioral interventions. Through usability testing, focus interviews, and field trials, investigators may modify the technologies and intervention based on immediate usage data.

The goal of this field trial is to tailor, and test, a peer networked intervention in adults 65 years of age or older. Two versions have been created and will be tested, one with and one without an online social network. The purpose of this study is to pilot a novel intervention, examine methods to improve adherence to Internet based interventions (e.g., peer network), and ultimately, to overcome the numerous barriers to treating depression in later life.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 47
• Est. completion date: September 2016
• Est. primary completion date: September 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Has elevated depressive symptoms

• Has a telephone, e-mail account, computer, and broadband access to the Internet.

• Has basic internet skills and is able to access the internet independently

• Is able to speak and read English.

• Is at least 65 years of age.

• Is able to give informed consent.

Exclusion Criteria:

• Has hearing or voice impairment that would prevent participation in psychotherapy

• Has visual impairment that would prevent use of the workbook and completion of assessment materials.

• Is diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, current post-traumatic stress disorder (PTSD), current substance abuse, or other diagnosis for which participation in a clinical trial of psychotherapy may be either inappropriate or dangerous.

• Is currently receiving individual psychotherapy or planning to receive psychotherapy during the 10-week treatment phase of the study (social networking site only)

• Is planning to be out of town or unavailable for an extended period of time during the study without access to the Internet

• Exhibits severe suicidality, including ideation, plan, and intent.

• Has initiated treatment with an antidepressant in past 14 days. Once patients have been on a stable dose for 14 days and do not have an appointment with a physician or psychiatrist to change this dose, the patient will be eligible based on this criterion.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Depression
• Depressive Disorder

Intervention

Other:
• Website

Behavioral:
• Coach support

• Network Peer Support

Locations

Country	Name	City	State
United States	Northwestern University	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
Northwestern University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Depression	Change in self-reported depressive symptom severity from baseline to end of treatment	Baseline to end of treatment (8 weeks)	No
Primary	Adherence to the application	Number of times accessed from start to last use from baseline to end of treatment (8 weeks)	Baseline to end of treatment	No